Scopio’s mission is to enable first-line early detection and diagnosis of hematological-based diseases and conditions such as cancers, anemia, and bleeding disorders, as well as bacterial and viral infections and allergies.
This is the promise of Full-Field digital cell morphology.
This is the safer, healthier future that Scopio is delivering to patients worldwide.